scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00125-017-4463-4 |
P698 | PubMed publication ID | 29067486 |
P50 | author | Lutz Heinemann | Q65055050 |
Richard M Bergenstal | Q90594281 | ||
P2093 | author name string | Anne L Peters | |
Reinhard W Holl | |||
John R Petrie | |||
G Alexander Fleming | |||
P2860 | cites work | Continuous glucose monitoring systems for type 1 diabetes mellitus | Q24203866 |
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and [...] | Q28071499 | ||
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities | Q28076888 | ||
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report | Q30276532 | ||
Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes | Q30276764 | ||
Multinational Home Use of Closed-Loop Control Is Safe and Effective | Q30276768 | ||
The evidence base for diabetes technology: appropriate and inappropriate meta-analysis | Q30409804 | ||
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. | Q33308776 | ||
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data | Q33954163 | ||
Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes | Q34856962 | ||
Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials | Q35337121 | ||
The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus | Q35337585 | ||
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry | Q35360823 | ||
Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes | Q35620189 | ||
Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis | Q35769485 | ||
Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring | Q36475919 | ||
IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial | Q36535939 | ||
Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. | Q36605704 | ||
Reimbursement for continuous glucose monitoring: a European view. | Q36605855 | ||
The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older | Q37054706 | ||
Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). | Q37275395 | ||
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial | Q37639313 | ||
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. | Q38025029 | ||
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial | Q38381853 | ||
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Techno | Q38382412 | ||
Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial | Q38443982 | ||
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial | Q38820633 | ||
Discrepancies Between Blood Glucose and Interstitial Glucose-Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target | Q38891664 | ||
Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline | Q38944771 | ||
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q39016044 | ||
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. | Q39376348 | ||
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise | Q39645480 | ||
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study). | Q41196180 | ||
Now Is the Time for a Cybersecurity Standard for Connected Diabetes Devices | Q42390675 | ||
CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring | Q43145838 | ||
Physiological differences between interstitial glucose and blood glucose measured in human subjects | Q44526994 | ||
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes | Q45112208 | ||
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline | Q46114434 | ||
Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 | ||
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes | Q46431323 | ||
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes | Q46659616 | ||
Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th | Q47825623 | ||
Threshold-based insulin-pump interruption for reduction of hypoglycemia. | Q50888948 | ||
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. | Q51107301 | ||
A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine. | Q51356590 | ||
SPECTRUM. | Q52848808 | ||
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). | Q53339287 | ||
Patient-reported outcomes and continuous glucose monitoring: can we do better with artificial pancreas devices? | Q87177705 | ||
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT | Q87234935 | ||
P433 | issue | 12 | |
P304 | page(s) | 2319-2328 | |
P577 | publication date | 2017-10-25 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. | |
P478 | volume | 60 |
Q64985848 | Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field. |
Q93107710 | Continuous Glucose Monitoring: A Review of Available Systems |
Q61805812 | Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System |
Q90641133 | Evaluating a Glucose-Sensor-Based Tool to Help Clinicians and Adults With Type 1 Diabetes Improve Self-Management Skills |
Q89477060 | Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes |
Q101043636 | Improved estimation of glycated hemoglobin with continuous glucose monitoring and past glycated hemoglobin data |
Search more.